A pharmaceutical field force represents one of the most significant operational investments a commercial pharma company makes: hundreds or thousands of sales representatives, medical science liaisons, and specialty account managers deployed across geographic territories, each carrying the company’s commercial message and building relationships with prescribers, payers, and health systems.
Managing a field force of this scale requires a deep commercial organization with specialized expertise in sales management, training, incentive compensation design, compliance, and field analytics. The pharma CEO’s role in field force management is one of strategic oversight, not operational management. Building the delegation system that makes this distinction real is the subject of this article.
The CEO’s Role in Field Force Strategy
The pharma CEO does not manage the field force. They set the commercial strategy that the field force executes and maintain oversight of the commercial leadership that manages field performance.
The CEO’s strategic field force responsibilities include:
Approving the field force structure and investment: how many representatives, which customer segments to target, and which channels to deploy alongside the field force. These decisions carry significant financial implications and competitive positioning consequences.
Setting the commercial strategy direction: which products to prioritize, what the value messages are, and how the field force should be positioned relative to competition.
Maintaining accountability for commercial performance: reviewing commercial metrics regularly and holding the Chief Commercial Officer accountable for field force productivity and outcomes.
Making major commercial investment decisions: field force expansion, restructuring, or significant incentive compensation model changes.
Everything below these strategic decisions is the commercial leadership team’s domain.
Assigning the Commercial Leadership Structure
A well-built pharmaceutical field force management delegation system requires a clear commercial leadership hierarchy. At the top is the Chief Commercial Officer (CCO) or VP of Commercial, who owns the total commercial function including field force strategy, sales operations, marketing, and market access.
Reporting to the CCO, a VP of Sales or Head of Field Force Management owns the operational management of the sales organization: managing regional and district sales managers, overseeing field performance, directing sales training, managing the incentive compensation program, and maintaining field compliance.
The CEO manages the CCO. The CCO manages the field force leadership structure. The CEO does not manage regional managers, attend district meetings, or engage with field representative performance outside of what the CCO dashboard provides.
For the broader commercial delegation framework in pharma, see pharma commercial strategy.
Delegating Sales Operations
Sales operations is the analytical and infrastructure function that supports the field force: territory alignment, call plan design, CRM management, field analytics, and incentive compensation calculation. A VP or Director of Sales Operations should own this function.
Their responsibilities include: maintaining the CRM and field reporting systems, producing field productivity analytics, coordinating territory and alignment changes, managing the incentive compensation calculation and dispute resolution process, and supporting field managers with the data and tools they need to manage their teams.
The CEO receives commercial performance summaries from the CCO that draw on sales operations data. The CEO does not engage with the underlying data systems or territory-level analytics directly.
Managing Incentive Compensation Design
Incentive compensation design is one of the most consequential field force management decisions: the incentive structure directly shapes what field representatives do and what they prioritize. This makes incentive compensation a strategic matter with significant compliance implications, particularly given FDA requirements around promotional activities.
A Compensation Committee or Sales Operations team, working with HR and Compliance, should develop the annual incentive compensation plan. The plan reflects the strategic priorities the CEO has set: which products to prioritize, what customer behaviors to reward, and how to align field motivation with organizational objectives.
The CEO approves the incentive compensation plan because it embodies commercial strategy. The CCO and Sales Operations function design, model, and recommend the plan. The CEO does not design the incentive structure from scratch or manage the compensation calculation process.
Field Force Compliance Delegation
Pharmaceutical field force compliance is one of the most regulated activities in the commercial space. FDA requirements around promotional messaging, sample management, healthcare professional interaction, and transparency reporting are extensive and enforced.
A Compliance Director or Head of Commercial Compliance should own the field compliance function: developing compliance training programs, monitoring field promotional activities, managing the medical-legal-regulatory review process for promotional materials, and conducting compliance audits of field activities.
The CEO sets the organizational expectation that compliance is non-negotiable and that commercial performance will never be rewarded if achieved through non-compliant behavior. The Compliance function operationalizes this expectation.
Major compliance failures, FDA warning letters, or significant investigations require CEO engagement. Routine compliance management belongs entirely to the compliance function.
Delegating Field Force Training
Sales training in pharmaceutical companies is a specialized function: representatives must understand the science behind the therapies they promote, the approved promotional claims they can make, the customer environment they operate in, and the selling skills they need to be effective.
A Training Director or Head of Field Training should own the training function. Their responsibilities include: developing initial and ongoing training curricula, managing training delivery, measuring training effectiveness, and updating training content as the competitive landscape or approved product information changes.
The CEO participates in new product launches by ensuring field training investment is adequate and that the launch readiness plan reflects the seriousness with which the company is approaching the commercial opportunity. The operational design and delivery of training programs belongs to the Training function.
Managing National Account and Key Account Relationships
In addition to the territory field force, pharmaceutical commercial organizations typically have national accounts or key account managers who manage relationships with large health systems, integrated delivery networks, group purchasing organizations, and managed care accounts.
A VP of National Accounts or Head of Key Account Management should own this function. Their responsibilities include managing the national account team, developing account strategies for major health systems, and coordinating between the field force and national account teams to ensure aligned customer engagement.
The CEO engages with key account relationships at the C-suite level for the most strategically significant accounts: health system CEOs, pharmacy benefit manager executives, or major integrated delivery network leadership where CEO-to-CEO engagement adds relationship value that the sales team cannot replicate.
According to McKinsey, pharmaceutical companies that redesign their commercial models to reflect the evolving customer landscape, with differentiated field force strategies for different customer segments, outperform competitors that maintain traditional sales force models, and this redesign requires CEO-level commercial strategy leadership paired with strong functional delegation.
Medical Science Liaison Delegation
Medical science liaisons (MSLs) operate at the intersection of medical affairs and commercial, engaging with key opinion leaders and clinical thought leaders on scientific topics. MSL management typically falls under Medical Affairs, not Sales, to preserve their independence from promotional activities.
The VP of Medical Affairs owns the MSL function. MSLs do not report into the sales management hierarchy, which is the structural protection for their non-promotional identity. The CEO ensures this structural boundary is maintained and that the MSL function is resourced appropriately for its scientific engagement mission.
Building the Commercial Performance Review System
The CEO maintains field force oversight through a structured commercial performance review system, not through direct field management. This system includes:
A monthly commercial performance dashboard covering territory-level sales performance, market share trends, field productivity metrics, and key account status updates. A quarterly business review (QBR) conducted with the CCO covering commercial performance trends, field force effectiveness analysis, competitive landscape implications, and strategic adjustments recommended for the coming quarter. An annual commercial planning review where the field force structure, investment, and incentive design for the coming year are assessed and approved.
The CEO reviews the monthly dashboard, participates in the quarterly business review, and leads the annual commercial planning approval process. Field performance management between these reviews belongs entirely to the commercial leadership team.
See pharma product launch for how field force deployment delegation integrates with the product launch planning framework.
Conclusion
Pharmaceutical field force management is one of the largest and most complex operational investments a commercial pharma company makes. The delegation system described here allows the CEO to maintain strategic ownership of commercial strategy, field force structure, and performance accountability while ensuring that the operational management of the field organization is led by capable commercial leaders with the expertise and daily engagement that effective field management requires.
Build the commercial leadership team, define the delegation boundaries, maintain the performance review rhythm, and lead the commercial strategy that gives the field force the direction and focus it needs to perform. That is the CEO’s field force role, and it is different from the regional manager’s or district manager’s role in every important way.
Related Reading
For further context, explore Delegation System for Automotive CEO: Compliance Team and Delegation System for Automotive CEO: Engineering Teams.